UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling

Zhiyi Cheng, Chao Yu, Guiyuan Liu, Bingbing Su, Longfei Dai, Xiaojun Zhao, Chuanjiang Huang

Open source

DOI
10.1007/s00011-026-02364-w
Published
2026-09-24
Container
Inflammation Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00011-026-02364-w,
  title = {UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling},
  author = {Zhiyi Cheng and Chao Yu and Guiyuan Liu and Bingbing Su and Longfei Dai and Xiaojun Zhao and Chuanjiang Huang},
  year = {2026},
  journal = {Inflammation Research},
  doi = {10.1007/s00011-026-02364-w},
  url = {https://doi.org/10.1007/s00011-026-02364-w}
}

RIS

TY  - JOUR
TI  - UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling
AU  - Zhiyi Cheng
AU  - Chao Yu
AU  - Guiyuan Liu
AU  - Bingbing Su
AU  - Longfei Dai
AU  - Xiaojun Zhao
AU  - Chuanjiang Huang
PY  - 2026
JO  - Inflammation Research
DO  - 10.1007/s00011-026-02364-w
UR  - https://doi.org/10.1007/s00011-026-02364-w
ER  - 

APA

Cheng, Z., Yu, C., Liu, G., Su, B., Dai, L., Zhao, X., & Huang, C. (2026). UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling. Inflammation Research. https://doi.org/10.1007/s00011-026-02364-w

Source records